- Home
- TCMD vs CHW Comparison
TCMD vs CHW Comparison
Compare TCMD & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCMD | CHW |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 570.4M | 523.0M |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TCMD | CHW |
|---|---|---|
| Price | $25.77 | $8.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | ★ 303.2K | 197.3K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.60 | N/A |
| Revenue Next Year | $9.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.34 | $6.69 |
| 52 Week High | $37.77 | $8.80 |
Technical Indicators
Market Signals| Indicator | TCMD | CHW |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 78.54 |
| Support Level | $25.38 | $7.08 |
| Resistance Level | $26.65 | N/A |
| Average True Range (ATR) | 1.51 | 0.15 |
| MACD | 0.33 | 0.05 |
| Stochastic Oscillator | 74.43 | 96.68 |
Price Performance
Historical ComparisonAbout TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities, and alternative investments.